预氧合:生理基础、获益与潜在风险
预氧合在麻醉诱导和气管插管前广泛使用,旨在增加体内氧储备、延迟呼吸暂停时动脉血红蛋白去饱和。本文讨论预氧合的生理基础、临床获益与潜在风险,并介绍延长其效果的多种方法及减少吸收性肺不张的策略。
要点
- 所有患者均应从预氧合中获益,因通气和插管困难难以预测。
- 最大预氧合终点为呼气末氧浓度90%或呼气末氮浓度5%。
- 预氧合可延迟呼吸暂停时去饱和,但高危患者获益可能减弱。
核心结论
- 预氧合通过增加体内氧储备延迟呼吸暂停时动脉血红蛋白去饱和,所有患者均适用。
- 预氧合的获益在高危患者中可能减弱,且存在吸收性肺不张等潜在风险。
研究设计与样本
- 本文为综述,讨论预氧合的生理基础、临床获益与潜在风险。
主要发现
- 所有研究均显示最大预氧合可显著延迟呼吸暂停时动脉血红蛋白去饱和。
- 预氧合的获益在高危患者中可能减弱。
- 预氧合潜在风险包括食管插管延迟发现、吸收性肺不张、活性氧产生及不良血流动力学效应。
关键数值与推荐
- 最大预氧合的疗效终点为呼气末氧浓度90%或呼气末氮浓度5%。
- 预氧合效率反映为呼吸暂停期间氧合血红蛋白去饱和的下降速率。
- 减少吸收性肺不张的方法包括将吸入氧浓度降至0.8及采用肺复张手法。
临床怎么用
- 麻醉诱导和气管插管前应常规预氧合,气管拔管前亦推荐预氧合。
- 可通过抬高头部、无呼吸扩散氧合、CPAP/PEEP、双水平正压通气及经鼻湿化快速充气通气交换延长预氧合效果。
局限性
- 预氧合持续时间短,血流动力学效应和活性氧积累不足以抵消其获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preoxygenation before anesthetic induction and tracheal intubation is a widely accepted maneuver, designed to increase the body oxygen stores and thereby delay the onset of arterial hemoglobin desaturation during apnea. Because difficulties with ventilation and intubation are unpredictable, the need for preoxygenation is desirable in all patients. During emergence from anesthesia, residual effects of anesthetics and inadequate reversal of neuromuscular blockade can lead to hypoventilation, hypoxemia, and loss of airway patency. In accordance, routine preoxygenation before the tracheal extubation has also been recommended. The objective of this article is to discuss the physiologic basis, clinical benefits, and potential concerns about the use of preoxygenation. The effectiveness of preoxygenation is assessed by its efficacy and efficiency. Indices of efficacy include increases in the fraction of alveolar oxygen, increases in arterial oxygen tension, and decreases in the fraction of alveolar nitrogen. End points of maximal preoxygenation (efficacy) are an end-tidal oxygen concentration of 90% or an end-tidal nitrogen concentration of 5%. Efficiency of preoxygenation is reflected in the rate of decline in oxyhemoglobin desaturation during apnea. All investigations have demonstrated that maximal preoxygenation markedly delays arterial hemoglobin desaturation during apnea. This advantage may be blunted in high-risk patients. Various maneuvers have been introduced to extend the effect of preoxygenation. These include elevation of the head, apneic diffusion oxygenation, continuous positive airway pressure (CPAP) and/or positive end-expiratory pressure (PEEP), bilevel positive airway pressure, and transnasal humidified rapid insufflation ventilatory exchange. The benefit of apneic diffusion oxygenation is dependent on achieving maximal preoxygenation, maintaining airway patency, and the existence of a high functional residual capacity to body weight ratio. Potential risks of preoxygenation include delayed detection of esophageal intubation, absorption atelectasis, production of reactive oxygen species, and undesirable hemodynamic effects. Because the duration of preoxygenation is short, the hemodynamic effects and the accumulation of reactive oxygen species are insufficient to negate its benefits. Absorption atelectasis is a consequence of preoxygenation. Two approaches have been proposed to reduce the absorption atelectasis during preoxygenation: a modest decrease in the fraction of inspired oxygen to 0.8, and the use of recruitment maneuvers, such as CPAP, PEEP, and/or a vital capacity maneuver (all of which are commonly performed during the administration of anesthesia). Although a slight decrease in the fraction of inspired oxygen reduces atelectasis, it does so at the expense of a reduction in the protection afforded during apnea.
引用
- Nimmagadda U, Salem MR, Crystal GJ, et al. Preoxygenation: Physiologic Basis, Benefits, and Potential Risks. Anesth Analg. 2017. PMID: 28099321. doi:10.1213/ANE.0000000000001589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。